VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Dersimelagon
Phase 3
Small molecule
T
Tanabe Pharma America, Inc.
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Clinical
Trials by Indication
[1]
Pain
1 trial
INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
Active, not recruiting
·
T
Tanabe Pharma America, Inc.
·
Phase 3
·
NCT06144840
·
165 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Dersimelagon. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Dersimelagon compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Dersimelagon. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Tanabe Pharma America, Inc. company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Phase 3
[1]
Company
T
Tanabe Pharma America, Inc.
Related News